FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to: medicine, and aims at treating cancer carrying EGFR mutations. What is declared is using BIBW 2992 (1) for preparing a pharmaceutical composition for treating patients suffering gefitinib and/or erlotinib resistant cancer.
EFFECT: using the declared invention is effective for treating the patients suffering cancer diseases with EGFR mutations in the tumour.
1 tbl, 10 ex
Title |
Year |
Author |
Number |
METHOD OF TREATING GEFITINIB-RESISTANT CANCER |
2006 |
- Khaber Dehniel
- Bell Dafis Uinifred
- Settlmehn Dzheffri E.
- Sordella Raffaehlla
- Goudin-Khejmann Nadja Dzh.
- Kvak Junis L.
- Rabindran Sridkhar Krishna
|
RU2405566C9 |
COMBINATION THERAPY USING DIARYL MACROCYCLIC COMPOUNDS |
2018 |
- Cui, Jingrong, Jean
- Zhai, Dayong
|
RU2784853C2 |
NEW COMBINATION OF 3-[(3-{[4-(4-MORPHOLINYLMETHYL)-1N-PYRROL-2-YL]METHYLENE}-2-OXO-2,3-DIHYDRO-1N-INDOL-5-YL)METHYL]-1,3-THIAZOLIDINE-2,4-DIONE AND TYROSINE KINASE INHIBITOR EGFR |
2016 |
- Berbridzh Majkl
- Kattan Valeri
- Zhak-Beskon Anne
|
RU2695362C2 |
COMBINATIONS (COMPOSITIONS), INCLUDING DMXAA FOR CANCER TREATMENT |
2006 |
- Grin Kolin
- Kelland Llojd
- Roulinson-Basza Gejl
|
RU2404765C2 |
USING PYRIMIDINE DERIVATIVES FOR TREATING EGFR-DEPENDENT DISEASES OR DISEASES WITH ACQUIRED RESISTANCE TO AGENTS AGAINST EGFR FAMILY |
2009 |
- Garsia-Ehcheverria Karlos
- Maira Sove-Mishel'
|
RU2496500C2 |
APPLICATION OF IMIDAZOQUINOLINES FOR TREATMENT OF EGFR-DEPENDENT DISEASES OR DISEASES WITH AQUIRED RESISTANCE TO AGENTS BINDING MEMBERS OF EGFR FAMILY |
2008 |
- Garsija-Ehcheverrija Karlos
- Maira Sove-Mishel'
|
RU2481838C2 |
TETRAHYDROFOLATES IN COMBINATION WITH EGFR INHIBITORS |
2013 |
- Gustavsson Bengt
- Karlsson Bern
|
RU2619335C2 |
COMBINED THERAPY |
2015 |
- Hao, Huaixiang
- Huang, Xizhong
- Tam, Angela
- Kasibhatla, Shailaja
|
RU2695230C2 |
ANTINEOPLASTIC COMBINATIONS CONTAINING HKI-272 AND VINORELBINE |
2009 |
|
RU2492860C2 |
COMBINATION THERAPY |
2013 |
- Khuan Sichzhun
- Peters Malte
- Tsao Chzhu Aleksander
- Gansert Dzhennifer Lorrejn
- Chang Devid Dong Eun
- Beltran Pedro
|
RU2677245C2 |